SE8002192L - Forfarande for framstellning av immunoglobulin for intravenos administration - Google Patents

Forfarande for framstellning av immunoglobulin for intravenos administration

Info

Publication number
SE8002192L
SE8002192L SE8002192A SE8002192A SE8002192L SE 8002192 L SE8002192 L SE 8002192L SE 8002192 A SE8002192 A SE 8002192A SE 8002192 A SE8002192 A SE 8002192A SE 8002192 L SE8002192 L SE 8002192L
Authority
SE
Sweden
Prior art keywords
immunoglobulin
purified
administration
intramuscular injections
intravenos
Prior art date
Application number
SE8002192A
Other languages
English (en)
Swedish (sv)
Inventor
N Yokoo
T Mori
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of SE8002192L publication Critical patent/SE8002192L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE8002192A 1979-03-22 1980-03-21 Forfarande for framstellning av immunoglobulin for intravenos administration SE8002192L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3347779A JPS55124719A (en) 1979-03-22 1979-03-22 Preparation of immune globulin administrable by intravenous injection

Publications (1)

Publication Number Publication Date
SE8002192L true SE8002192L (sv) 1980-09-23

Family

ID=12387617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002192A SE8002192L (sv) 1979-03-22 1980-03-21 Forfarande for framstellning av immunoglobulin for intravenos administration

Country Status (6)

Country Link
US (1) US4256631A (xx)
JP (1) JPS55124719A (xx)
DE (1) DE3010801C2 (xx)
FR (1) FR2451745A1 (xx)
GB (1) GB2044775B (xx)
SE (1) SE8002192L (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
US4490290A (en) * 1981-02-26 1984-12-25 Internationale Octrooi Maatschappij "Octropa" B.V. Process for the recovery of immunoglobulins
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
EP0215775A1 (en) * 1985-03-13 1987-04-01 Nordisk Gentofte A/S Immunosorbent for removal of rheumatoid factors from whole blood or blood plasma
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
CA1308023C (en) * 1988-07-29 1992-09-29 William Austin James Mcauley Immunoglobulin extraction utilizing properties of colloidal solutions
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US20040101909A1 (en) * 2002-08-20 2004-05-27 Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 Purification of polyreactive autoantibodies and uses thereof
US8372287B2 (en) * 2008-09-02 2013-02-12 Als Group Usa, Corp Impregnated expanded polytetrafluoroethylene (ePTFE) tubing as a stationary phase
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
GB201717446D0 (en) * 2017-10-24 2017-12-06 Evox Therapeutics Ltd Affinity purification of engineering extracellular vesicles
JP2023526738A (ja) * 2020-04-10 2023-06-23 プラズマ テクノロジーズ エルエルシー タンパク質の単純化した高効率単離のための組成物および方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US3641235A (en) * 1968-11-01 1972-02-08 Miles Lab Immunological reagent and process for making same
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
FR2279419A1 (fr) * 1974-07-25 1976-02-20 Merieux Inst Procede de preparation d'immunoglobulines purifiees, immunoglobulines purifiees obtenues et un medicament comprenant ces immunoglobulines purifiees
GB1541435A (en) * 1975-02-04 1979-02-28 Searle & Co Immunological materials
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin

Also Published As

Publication number Publication date
GB2044775A (en) 1980-10-22
DE3010801A1 (de) 1980-10-02
DE3010801C2 (de) 1983-06-09
FR2451745A1 (fr) 1980-10-17
JPS55124719A (en) 1980-09-26
FR2451745B1 (xx) 1984-01-27
JPS62885B2 (xx) 1987-01-10
US4256631A (en) 1981-03-17
GB2044775B (en) 1982-12-01

Similar Documents

Publication Publication Date Title
SE8002192L (sv) Forfarande for framstellning av immunoglobulin for intravenos administration
ES515177A0 (es) Procedimiento para el tratamiento de inmunoglobulina de suero.
DE58905514D1 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt.
ATE117900T1 (de) Verfahren zur herstellung nicht modifizierter intravenös verabreichbarer igm- und/oder iga- haltige immunglobulinpräparate.
EP0659767B1 (de) Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
DE3485649D1 (de) Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit.
SE7907045L (sv) Forfarande for framstellning av ett intravenost administrerbart antikroppshaltigt immunglobulinpreparat och enligt forfarandet framstellda preparat
DE59208982D1 (de) Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
DE2527064A1 (de) Intravenoeses nativ-human-immunglobulin mit natuerlicher halbwertszeit
FI903464A0 (fi) Foerfarande foer oxiderande denaturering av proteinanalyter.
ATE9905T1 (de) Herstellung von immunoglobulin mit hohem monomer- anteil.
DK81691D0 (da) Fremgangsmaade til forhindring eller reduktion af eosinofili
ATA212683A (de) Verfahren zur herstellung einer verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation die intravenoese applikation
Miller et al. Production of acute glomerulonephritis in mice with soluble antigen-antibody complexes prepared from homologous antibody.
McCluskey Evidence for immunologic mechanisms in several forms of human glomerular diseases.
ATE401912T1 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
EP0406216A2 (de) Protein-S-hältige pharmazeutische Präparation
DE3018901C2 (de) Verfahren zur Herstellung von Immunoglobulinderivaten
Sato Studies on the fractionation of Haemophilus pertussis antitoxin
Skvaril et al. Anticomplementary properties of plasmin-treated human G immunoglobulin and its components
Hartman Bioavailability study of diphtheria immunoglobulin (human)
Witz et al. Brain Localizing Activity of Hetero-and Isoimmune Sera Directed against Lymphocytic Cells
Kishida et al. An improved method for the production of antisera to G1m allotypes
JPS5221316A (en) Process for preparing immuno-globulin derivatives possessing glutathio ne units
GB1517026A (en) Immune globulins and process for their preparation

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002192-6

Format of ref document f/p: F